Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UPDATE 1-UK Stocks-Factors to watch on May 29

Published 29/05/2020, 08:53
Updated 29/05/2020, 08:57
© Reuters.

(Adds futures, news items)

May 29 (Reuters) - Britain's FTSE 100 index is seen opening 52 points lower on Friday, according to financial bookmakers, with futures FFIc1 down 0.9%.

* B&M: B&M BMEB.L said it had traded strongly over the last two months, driven by exceptional demand for do-it-yourself and gardening products during the national lockdown.

* NATIONWIDE: Nationwide Building Society's POB_p.L annual profit fell by 44%, it said as it warned of rising loan losses because of the coronavirus pandemic.

* SIG: SIG Plc SHI.L plans to raise 150 million pounds in new equity with U.S. buyout firm Clayton, Dubilier & Rice, it said, as it pointed to a bleak outlook after "disappointing" results.

* JOBS: Britain cannot run its COVID-19 jobs protection scheme indefinitely and needs to start tapering it down as people slowly return to work, environment minister George Eustice said.

* AUTOMOBILE: British car production could slump this year to the lowest level in decades after the pandemic forced factories to close and hit demand, according to an industry body.

* ASTRAZENECA: AstraZeneca's AZN.L top-selling drug Tagrisso has been shown to hold back a certain type of lung cancer when diagnosed at an early stage, the British drugmaker said on Thursday.

* GOLD: Gold inched up and was on track for its second monthly gain as deteriorating U.S.-China ties in a world reeling from the virus outbreak rattled investors and fuelled demand for the safe-haven metal.

* OIL: Oil prices edged lower after U.S. inventory data showed lacklustre fuel demand in the world's largest oil consumer.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

* UK shares ended higher on Thursday, helped by drugmakers AstraZeneca and GSK as markets looked for more progress in the development of a COVID-19 vaccine.

For more on the factors affecting European stocks, please click on: LIVE/

TODAY'S UK PAPERS

> Financial Times PRESS/FT

> Other business headlines PRESS/GB

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.